» Articles » PMID: 11547053

Prospective Randomized Trial Comparing Shock Wave Lithotripsy and Ureteroscopy for Management of Distal Ureteral Calculi

Overview
Journal J Urol
Publisher Wolters Kluwer
Specialty Urology
Date 2001 Sep 8
PMID 11547053
Citations 41
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: We compared the efficacy of shock wave lithotripsy and ureteroscopy for treatment of distal ureteral calculi.

Materials And Methods: A total of 64 patients with solitary, radiopaque distal ureteral calculi 15 mm. or less in largest diameter were randomized to treatment with shock wave lithotripsy (32) using an HM3 lithotriptor (Dornier MedTech, Kennesaw, Georgia) or ureteroscopy (32). Patient and stone characteristics, treatment parameters, clinical outcomes, patient satisfaction and cost were assessed for each group.

Results: The 2 groups were comparable in regard to patient age, sex, body mass index, stone size, degree of hydronephrosis and time to treatment. Procedural and operating room times were statistically significantly shorter for the shock wave lithotripsy compared to the ureteroscopy group (34 and 72 versus 65 and 97 minutes, respectively). In addition, 94% of patients who underwent shock wave lithotripsy versus 75% who underwent ureteroscopy were discharged home the day of procedure. At a mean followup of 21 and 24 days for shock wave lithotripsy and ureteroscopy, respectively, 91% of patients in each group had undergone imaging with a plain abdominal radiograph, and all studies showed resolution of the target stone. Minor complications occurred in 9% and 25% of the shock wave lithotripsy and ureteroscopy groups, respectively (p value was not significant). No ureteral perforation or stricture occurred in the ureteroscopy group. Postoperative flank pain and dysuria were more severe in the ureteroscopy than shock wave lithotripsy group, although the differences were not statistically significant. Patient satisfaction was high, including 94% for shock wave lithotripsy and 87% for ureteroscopy (p value not significant). Cost favored ureteroscopy by $1,255 if outpatient treatment for both modalities was assumed.

Conclusions: Ureteroscopy and shock wave lithotripsy were associated with high success and low complication rates. However, shock wave lithotripsy required significantly less operating time, was more often performed on an outpatient basis, and showed a trend towards less flank pain and dysuria, fewer complications and quicker convalescence. Patient satisfaction was uniformly high in both groups. Although ureteroscopy and shock wave lithotripsy are highly effective for treatment of distal ureteral stones, we believe that HM3 shock wave lithotripsy, albeit slightly more costly, is preferable to manipulation with ureteroscopy since it is equally efficacious, more efficient and less morbid.

Citing Articles

Prospective comparison of extracorporeal shock wave lithotripsy and ureteroscopy in distal ureteral stones.

Gong Z, Li Y, Zhang H, Pan C, Li J, Liu G Urolithiasis. 2023; 51(1):86.

PMID: 37272997 DOI: 10.1007/s00240-023-01460-4.


The Efficiency of Extracorporeal Shock Wave Lithotripsy (ESWL) in the Treatment of Distal Ureteral Stones: An Unjustly Forgotten Option?.

Alic J, Heljic J, Hadziosmanovic O, Kulovac B, Lepara Z, Spahovic H Cureus. 2022; 14(9):e28671.

PMID: 36196280 PMC: 9525100. DOI: 10.7759/cureus.28671.


Cost-utility analysis of shockwave lithotripsy vs ureteroscopic stone treatment in adults.

Kilonzo M, Dasgupta R, Thomas R, Aucott L, MacLennan S, Lam T BJU Int. 2022; 131(2):253-261.

PMID: 35974700 PMC: 10087721. DOI: 10.1111/bju.15862.


Shockwave lithotripsy compared with ureteroscopic stone treatment for adults with ureteric stones: the TISU non-inferiority RCT.

Dasgupta R, Cameron S, Aucott L, MacLennan G, Kilonzo M, Lam T Health Technol Assess. 2022; 26(19):1-70.

PMID: 35301982 PMC: 8958411. DOI: 10.3310/WUZW9042.


Re-Treatment after Ureteroscopy and Shock Wave Lithotripsy: A Population Based Comparative Effectiveness Study.

Bowen D, Song L, Faerber J, Kim J, Scales Jr C, Tasian G J Urol. 2019; 203(6):1156-1162.

PMID: 31859598 PMC: 7211122. DOI: 10.1097/JU.0000000000000712.